Microbot Medical (STU:CY9D) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:CY9D Microbot Medical Inc STU:CY9D
25 GF Score
Price €1.46
! 3 Warning Signs
View Full Analysis

What is Microbot Medical Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

STU:CY9D
25GF Score
Microbot Medical Inc STU:CY9D
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbot Medical Business Description

Other Exchanges MBOT:USACY9D:Germany
Address 175 Derby Street, Building 27, Hingham, MA, USA, 02043
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
25GF Score

Get the complete analysis for STU:CY9D

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.46
Price